Huadong Medicine Co Ltd Market Cap ($6.64 Billion)
Market Cap & Net Worth: Huadong Medicine Co Ltd (000963)
Huadong Medicine Co Ltd market cap. Huadong Medicine Co Ltd (SHE:000963) has a market capitalization of $6.64 Billion (CN¥45.39 Billion) as of October 31, 2026. Listed on the SHE stock exchange, this China-based company holds position #2884 globally and #308 in its home market, demonstrating a -2.67% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Huadong Medicine Co Ltd's stock price CN¥25.88 by its total outstanding shares 1754021048 (1.75 Billion).
Huadong Medicine Co Ltd Market Cap History (2015–2026)
Huadong Medicine Co Ltd market cap history from 2015 to 2026. Data shows growth from $5.12 Billion to $6.64 Billion (3.24% CAGR). Check 000963 stock price and chart for real-time trading data and today's change.
Huadong Medicine Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Huadong Medicine Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see Huadong Medicine Co Ltd (000963) cash flow conversion for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
0.21x
Huadong Medicine Co Ltd's market cap is 0.21 times its annual revenue
Latest Price to Earnings (P/E) Ratio
2.53x
Huadong Medicine Co Ltd's market cap is 2.53 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $5.12 Billion | $21.73 Billion | $1.10 Billion | 0.24x | 4.67x |
| 2016 | $4.59 Billion | $25.38 Billion | $1.45 Billion | 0.18x | 3.17x |
| 2017 | $7.07 Billion | $27.83 Billion | $1.78 Billion | 0.25x | 3.97x |
| 2018 | $5.26 Billion | $30.66 Billion | $2.27 Billion | 0.17x | 2.32x |
| 2019 | $5.88 Billion | $35.45 Billion | $2.81 Billion | 0.17x | 2.09x |
| 2020 | $6.48 Billion | $33.68 Billion | $2.82 Billion | 0.19x | 2.30x |
| 2021 | $9.86 Billion | $34.56 Billion | $2.30 Billion | 0.29x | 4.28x |
| 2022 | $11.56 Billion | $37.71 Billion | $2.50 Billion | 0.31x | 4.63x |
| 2023 | $10.32 Billion | $40.62 Billion | $2.84 Billion | 0.25x | 3.63x |
| 2024 | $8.88 Billion | $41.91 Billion | $3.51 Billion | 0.21x | 2.53x |
Competitor Companies of 000963 by Market Capitalization
Companies near Huadong Medicine Co Ltd in the global market cap rankings as of October 31, 2026. See Huadong Medicine Co Ltd (000963) balance sheet quality index to understand what proportion of total assets are financed by equity.
Key companies related to Huadong Medicine Co Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #515 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #536 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #600 globally with a market cap of $45.38 Billion USD ( CN¥310.15 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #626 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #515 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #536 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $45.98 |
| #600 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.38 Billion | CN¥48.62 |
| #626 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €17.90 |
Market Capitalization of Huadong Medicine Co Ltd (2015–2026)
Market capitalization of Huadong Medicine Co Ltd from 2015 to today. Between 2015 and today, Huadong Medicine Co Ltd's market cap moved from $5.12 Billion to $ 6.64 Billion, with a yearly change of 3.24%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥6.64 Billion | -34.40% |
| 2025 | CN¥10.13 Billion | +14.02% |
| 2024 | CN¥8.88 Billion | -13.91% |
| 2023 | CN¥10.32 Billion | -10.77% |
| 2022 | CN¥11.56 Billion | +17.24% |
| 2021 | CN¥9.86 Billion | +52.12% |
| 2020 | CN¥6.48 Billion | +10.24% |
| 2019 | CN¥5.88 Billion | +11.81% |
| 2018 | CN¥5.26 Billion | -25.62% |
| 2017 | CN¥7.07 Billion | +54.02% |
| 2016 | CN¥4.59 Billion | -10.38% |
| 2015 | CN¥5.12 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 30th, 2026 the market cap of Huadong Medicine Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.64 Billion USD |
| MoneyControl | $6.64 Billion USD |
| MarketWatch | $6.64 Billion USD |
| marketcap.company | $6.64 Billion USD |
| Reuters | $6.64 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Huadong Medicine Co Ltd
Huadong Medicine Co., Ltd, together with its subsidiaries, engages in the wholesale and retail of pharmaceutical products in China and internationally. It operates through Pharmaceutical Industry, Pharmaceutical Business, Aesthetic Medicine, and Industrial Microbiology segments. The company distributes Chinese and western medicines, Chinese herbal medicines, and medical instruments; and immunosup… Read more